FOXF2 and breast cancer: Our data suggest that patients with low FOXF2 mRNA levels have a high risk of early-onset relapse and metastasis, and in histological grade II breast cancer, FOXF2 mRNA levels in primary cancer tissues predict the prognosis of patients.